Before you continue

LivingLabs.Blog is for learning — not medical advice. Some peptides we cover are research compounds and aren't FDA-approved. Always talk to a qualified healthcare provider before starting anything. Everyone reacts differently, and we don't sell peptides or recommend vendors.

We use cookies to understand how the site is used and improve it. See how we handle your data in our privacy practices.

Home / Blogs / Blog / Comparison of Retatrutide to new GLP-4 compounds

Back to Blog

Blog 1 min read June 6, 2026

Twitter / X
Facebook
LinkedIn
Email

Comparison of Retatrutide to new GLP-4 compounds

A user discussed a new drug candidate (NA-931) and compared its efficacy to Retatrutide, noting that Retatrutide is known for significant weight loss effects. The comparison highlighted Retatrutide’s potency in the GLP-1/GIP/GCG agonist category.

Dosing guides

Single peptides
Blends
Stacks
All dosing guides

Resources

How to mix a peptide
Dose calculator
Articles
Common questions
Starter Guide
Injection 101
How to Use This Site

Join the list

New research, dosing tips, and easy-to-read guides — sent straight to your inbox.

No spam, ever. Unsubscribe whenever you like.

A quick heads-up

Everything on LivingLabs.Blog is for learning — not medical advice. Some peptides we cover are research compounds and aren't FDA-approved. Always talk to a qualified healthcare provider before starting anything. Everyone reacts differently. We don't sell peptides or recommend vendors.

We cite peer-reviewed research wherever we can.